The risk of venous thromboembolism in patients with heart failure
Aim. To quantify the risk of venous thromboembolism (VTE) in hospitalized patients, depending on the severity of heart failure (HF).Material and methods. Current cross-sectional study included 132 patients hospitalized in the cardiology department in 2019. All participants were divided into 2 groups...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2020-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3678 |
id |
doaj-3484ad9ef1cc41e8b6dae669ed4a2eb5 |
---|---|
record_format |
Article |
spelling |
doaj-3484ad9ef1cc41e8b6dae669ed4a2eb52021-07-28T14:02:38Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202020-02-0125110.15829/1560-4071-2020-1-36782825The risk of venous thromboembolism in patients with heart failureN. K. Vereina0D. G. Agasyan1V. S. Chulkov2South Ural State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical UniversityAim. To quantify the risk of venous thromboembolism (VTE) in hospitalized patients, depending on the severity of heart failure (HF).Material and methods. Current cross-sectional study included 132 patients hospitalized in the cardiology department in 2019. All participants were divided into 2 groups: group 1 (n=48) — patients with class I-II HF; group 2 (n=84) — patients with class III-IV HF. A total quantitative assessment of the VTE risk was carried out according to the Caprini risk scoring method.Results. All patients hospitalized in the cardiology department, regardless of HF class, had a moderate and high risk of VTE and required prophylactic anticoagulation. High VTE risk had 85% of patients with class I-II HF; 97,6% — patients with a class III-IV HF. Mean score of ≥10 was observed in every fifth patient. Atrial fibrillation requiring long-term anticoagulant therapy was observed in 51,5% of patients. There were no absolute contraindications for parenteral prophylactic anticoagulation at the time of hospitalization in the study population.Conclusion. All patients admitted to the cardiology department had a moderate and high according to the Caprini risk score, regardless of HF class. More than half of the patients had indications for long-term anticoagulant therapy. The remaining patients required the parenteral prophylactic anticoagulation.https://russjcardiol.elpub.ru/jour/article/view/3678heart failurevenous thromboembolismprevention |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
N. K. Vereina D. G. Agasyan V. S. Chulkov |
spellingShingle |
N. K. Vereina D. G. Agasyan V. S. Chulkov The risk of venous thromboembolism in patients with heart failure Российский кардиологический журнал heart failure venous thromboembolism prevention |
author_facet |
N. K. Vereina D. G. Agasyan V. S. Chulkov |
author_sort |
N. K. Vereina |
title |
The risk of venous thromboembolism in patients with heart failure |
title_short |
The risk of venous thromboembolism in patients with heart failure |
title_full |
The risk of venous thromboembolism in patients with heart failure |
title_fullStr |
The risk of venous thromboembolism in patients with heart failure |
title_full_unstemmed |
The risk of venous thromboembolism in patients with heart failure |
title_sort |
risk of venous thromboembolism in patients with heart failure |
publisher |
«FIRMA «SILICEA» LLC |
series |
Российский кардиологический журнал |
issn |
1560-4071 2618-7620 |
publishDate |
2020-02-01 |
description |
Aim. To quantify the risk of venous thromboembolism (VTE) in hospitalized patients, depending on the severity of heart failure (HF).Material and methods. Current cross-sectional study included 132 patients hospitalized in the cardiology department in 2019. All participants were divided into 2 groups: group 1 (n=48) — patients with class I-II HF; group 2 (n=84) — patients with class III-IV HF. A total quantitative assessment of the VTE risk was carried out according to the Caprini risk scoring method.Results. All patients hospitalized in the cardiology department, regardless of HF class, had a moderate and high risk of VTE and required prophylactic anticoagulation. High VTE risk had 85% of patients with class I-II HF; 97,6% — patients with a class III-IV HF. Mean score of ≥10 was observed in every fifth patient. Atrial fibrillation requiring long-term anticoagulant therapy was observed in 51,5% of patients. There were no absolute contraindications for parenteral prophylactic anticoagulation at the time of hospitalization in the study population.Conclusion. All patients admitted to the cardiology department had a moderate and high according to the Caprini risk score, regardless of HF class. More than half of the patients had indications for long-term anticoagulant therapy. The remaining patients required the parenteral prophylactic anticoagulation. |
topic |
heart failure venous thromboembolism prevention |
url |
https://russjcardiol.elpub.ru/jour/article/view/3678 |
work_keys_str_mv |
AT nkvereina theriskofvenousthromboembolisminpatientswithheartfailure AT dgagasyan theriskofvenousthromboembolisminpatientswithheartfailure AT vschulkov theriskofvenousthromboembolisminpatientswithheartfailure AT nkvereina riskofvenousthromboembolisminpatientswithheartfailure AT dgagasyan riskofvenousthromboembolisminpatientswithheartfailure AT vschulkov riskofvenousthromboembolisminpatientswithheartfailure |
_version_ |
1721268883400163328 |